Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mogensen

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Phenylcyanoguanidines as inhibitors of glucose-induced insulin secretion from beta cellsT M Tagmose, J P Mogensen, P C Agerholm, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Design of a partial PPARdelta agonistIngrid Pettersson, Søren Ebdrup, Miroslav Havranek, et al.
The Journal of Urology|March 1, 1997
Estramustine phosphate versus placebo as second line treatment after orchiectomy in patients with metastatic prostate cancer: DAPROCA study 9002. Danish Prostatic Cancer GroupP Iversen, F Rasmussen, C Asmussen, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1989
LHRH analogue as a depot preparation (Zoladex) in the treatment of advanced carcinoma of the prostate followed by orchiectomy as a second line therapy--a phase II studyP Iversen, C Rose, J G Stage, et al.
British Journal of Neurosurgery|December 17, 2008
Neuromodulation in a minipig MPTP model of Parkinson diseaseC R Bjarkam, M S Nielsen, A N Glud, et al.
Cancer|September 1, 1990
A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostateP Iversen, M G Christensen, E Friis, et al.
Bioorganic & Medicinal Chemistry|March 5, 2003
Synthesis and biological activity of 3,3-diamino-sulfonylacrylonitriles as novel inhibitors of glucose induced insulin secretion from beta cellsTina M Tagmose, Florencio Zaragoza, Harrie C M Boonen, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2007
Design of potent PPARalpha agonistsPer Sauerberg, John P Mogensen, Lone Jeppesen, et al.
Journal of Developmental Origins of Health and Disease|December 18, 2014
Effects of an outdoor bicycle-based intervention in healthy rural Indian men with normal and low birth weightC Madsen, P Mogensen, N Thomas, et al.
Journal of Medicinal Chemistry|October 31, 2003
Large dimeric ligands with favorable pharmacokinetic properties and peroxisome proliferator-activated receptor agonist activity in vitro and in vivoPer Sauerberg, Paul S Bury, John P Mogensen, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Phenylcyanoguanidines as inhibitors of glucose-induced insulin secretion from beta cellsT M Tagmose, J P Mogensen, P C Agerholm, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Design of a partial PPARdelta agonistIngrid Pettersson, Søren Ebdrup, Miroslav Havranek, et al.
The Journal of Urology|March 1, 1997
Estramustine phosphate versus placebo as second line treatment after orchiectomy in patients with metastatic prostate cancer: DAPROCA study 9002. Danish Prostatic Cancer GroupP Iversen, F Rasmussen, C Asmussen, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1989
LHRH analogue as a depot preparation (Zoladex) in the treatment of advanced carcinoma of the prostate followed by orchiectomy as a second line therapy--a phase II studyP Iversen, C Rose, J G Stage, et al.
British Journal of Neurosurgery|December 17, 2008
Neuromodulation in a minipig MPTP model of Parkinson diseaseC R Bjarkam, M S Nielsen, A N Glud, et al.
Cancer|September 1, 1990
A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostateP Iversen, M G Christensen, E Friis, et al.
Bioorganic & Medicinal Chemistry|March 5, 2003
Synthesis and biological activity of 3,3-diamino-sulfonylacrylonitriles as novel inhibitors of glucose induced insulin secretion from beta cellsTina M Tagmose, Florencio Zaragoza, Harrie C M Boonen, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2007
Design of potent PPARalpha agonistsPer Sauerberg, John P Mogensen, Lone Jeppesen, et al.
Journal of Developmental Origins of Health and Disease|December 18, 2014
Effects of an outdoor bicycle-based intervention in healthy rural Indian men with normal and low birth weightC Madsen, P Mogensen, N Thomas, et al.
Journal of Medicinal Chemistry|October 31, 2003
Large dimeric ligands with favorable pharmacokinetic properties and peroxisome proliferator-activated receptor agonist activity in vitro and in vivoPer Sauerberg, Paul S Bury, John P Mogensen, et al.
Pageof 8